Trial NCT03373305

View at ClinicalTrials.gov 
Org. Study IDs: 17347
Secondary IDs: NCI-2017-02163

Last trial update was posted on 2019-04-30

MeSH Interventions

Antibodies Antibodies, Monoclonal Antineoplastic Agents, Immunological Brentuximab Vedotin Immunoconjugates Immunoglobulins Lenalidomide Piperidine

MeSH Conditions

Lymphoma Lymphoma, Non-Hodgkin Lymphoma, T-Cell Lymphoma, T-Cell, Cutaneous Mycoses Mycosis Fungoides Recurrence Sezary Syndrome

Other Conditions

CD30-Positive Neoplastic Cells Present Folliculotropic Mycosis Fungoides Recurrent Mycosis Fungoides Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma Refractory Mycosis Fungoides Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma

Stopping Reasons

contract not executed

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID